By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medicines for Malaria Venture (MMV) 

20, rte de Pré-Bois

Geneva 15    1215  Switzerland
Phone: 41-0-22-799-4060 Fax: 41-0-22-799-4061




Company News
Anacor Pharmaceuticals, Inc. and Medicines for Malaria Venture (MMV) Extend Development Agreement for AN3661 for the Treatment of Malaria 9/1/2011 9:04:27 AM
Anacor Pharmaceuticals, Inc. Announces Development Agreement with Medicines for Malaria Venture (MMV) for the Treatment of Malaria 3/18/2011 10:53:00 AM
Jomaa Pharma and Medicines for Malaria Venture (MMV) to Co-Develop Novel Malaria Treatment Based on Fosmidomycin 2/15/2011 10:25:53 AM
Alnylam Pharmaceuticals (ALNY) Release: Medicines for Malaria Venture (MMV) Becomes First Product Development Partnership to Contribute Patents to the Pool for Open Innovation against Neglected Tropical Diseases 8/16/2010 8:21:55 AM
Medicines for Malaria Venture (MMV) and Anacor Pharmaceuticals, Inc. Announce Collaboration to Apply Boron Chemistry Technology to Identify New Medicines for the Treatment of Malaria 4/26/2010 10:56:38 AM
SCYNEXIS, Inc. And Medicines for Malaria Venture (MMV) Sign HEOS(R) Agreement 5/13/2009 10:08:49 AM
Pfizer Inc. (PFE) and Medicines for Malaria Venture (MMV) Advancing International Research Efforts in the Fight against Malaria 4/22/2009 11:49:50 AM
BioFocus DPI And Medicines for Malaria Venture (MMV) Collaborate To Identify Anti-Malarial Compounds 4/16/2009 11:25:31 AM
Malaria: New Treatment is Upcoming Developed by the Italian Pharmaceutical Company sigma-tau New Data Confirm the Absence of Side Effects and the Benefit of the Simpler Treatment Schedule 1/16/2009 10:29:16 AM
Progress by Genzyme Corporation (GENZ), the Broad Institute and Medicines for Malaria Venture (MMV) Toward Developing Drug Candidates for Malaria Highlighted at Tropical Medicine Meeting 12/12/2008 8:56:38 AM